Rainsberger Wealth Advisors’s AbbVie ABBV Stock Holding History

Rainsberger Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,897	Closed	-$2.53M	–	68
2023 Q1	$2.53M	Buy	15,897 +1,100	+7%	+$168K	1.5%	21
2022 Q4	$2.39M	Buy	14,797 +212	+1%	+$32.5K	1.52%	20
2022 Q3	$1.96M	Buy	14,585 +326	+2%	+$46.8K	1.34%	22
2022 Q2	$2.18M	Buy	14,259 +26	+0.2%	+$3.97K	1.6%	19
2022 Q1	$2.31M	Buy	14,233 +714	+5%	+$104K	1.48%	20
2021 Q4	$1.83M	Buy	+13,519	New	+$1.6M	1.07%	28

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rainsberger Wealth Advisors's ABBV Position: Q2 2023 in Review

Rainsberger Wealth Advisors sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 15,897 shares — an estimated $2.53M sold.

Rainsberger Wealth Advisors first reported a position in ABBV in Q4 2021 and held it in 6 quarters. The position peaked at $2.53M in Q1 2023. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Rainsberger Wealth Advisors reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
Rainsberger Wealth Advisors sold 15,897 AbbVie shares in Q2 2023, an estimated $2.53M.
Rainsberger Wealth Advisors first reported a position in AbbVie in Q4 2021 and held it in 6 quarters.
Rainsberger Wealth Advisors's AbbVie position peaked at $2.53M in Q1 2023.
3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Rainsberger Wealth Advisors's 13F filing for Q2 2023, filed 7 Aug 2023.